Last reviewed · How we verify

High dose TSO

Dr. Falk Pharma GmbH · Phase 2 active Small molecule

Treats Cryptococcal meningitis by inhibiting the cell wall synthesis of Cryptococcus neoformans

Treats Cryptococcal meningitis by inhibiting the cell wall synthesis of Cryptococcus neoformans Used for Cryptococcal meningitis.

At a glance

Generic nameHigh dose TSO
SponsorDr. Falk Pharma GmbH
Drug classPolyene antifungal
TargetErgosterol
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhasePhase 2

Mechanism of action

High dose TSO is a form of liposomal amphotericin B, which is a polyene antifungal medication. It works by binding to ergosterol in the fungal cell membrane, leading to cell lysis and death.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results